which country? [Design Issues]

posted by Jaime_R – Barcelona, 2006-06-14 20:07 (7304 d 02:45 ago) – Posting: # 146
Views: 10,978

Dear Nguyen,

would you please provide us with a little more informations, namely:

- in which country will the clinical part of the studies be performed, and
- in which country/countries will you go for regulatory submission.

Background: regulations differ from country to country if no reference product is (no more) registered.

Regards, Jaime

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
97 visitors (0 registered, 97 guests [including 17 identified bots]).
Forum time: 22:52 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5